Azurity Pharmaceuticals, Inc. vs. EXELIXIS, INC.

Explore the PTAB proceeding IPR2025-00210 filed by Azurity Pharmaceuticals, Inc. on 2024-11-18. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2025-00210

Filing Date

2024-11-18

Accorded Filing Date

2024-11-18

Institution Decision Date

2025-06-04

Last Modified Date

2025-10-06

Proceeding Type

IPR

Termination Date

2025-06-04

Trial Status

Institution Denied

Parties & Counsel

Petitioner

Azurity Pharmaceuticals, Inc.

Represented By

Morrell, Andrewet al

Patent Owner / Respondent

EXELIXIS, INC.

Represented By

Whelan, Emilyet al

Tribunal & Venue

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Patent Information

1 Patent Involved

Respondent Application Number 17170275

Respondent Patent Number 11298349

External Links

Espacenet

Google Patents

Respondent Inventor Jo Ann Wilson et al

Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Address and Attorney/Agent Information

21 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name JONATHAN P. O''BRIEN, PH.D./Exelixis - HONIGMAN LLP

Customer Number 91684

Address 650 Trade Centre Way, Suite 200, Kalamazoo, MI, 49002-0402, UNITED STATES

Attorney / Agent Information

Reg #	Name	Phone
31060	Pamela Simonton	650-344-9441
34251	Douglas Siegel	616-649-1920
34440	Eric Sosenko	734-418-4252
35004	Thomas Wootton	269-337-7706
40259	Lucy Yang	269-337-7746
48951	Heidi Berven	269-337-7710
49048	Timothy Bogel	248-566-8526
50852	Jonathan O'Brien	269-337-7704
52377	Zhe Wu	650-837-7000
53665	Matthew Szalach	248-566-8662
54243	Brett Krueger	616-649-1970
55888	Andrew Weber	269-337-7700
59348	Thomas Appledorn	248-566-8522
60258	Kathryn Doyle	269-337-7836
60403	Kelly Murphy	269-337-7834
62418	Christopher Forbes	269-337-7852
62688	Fernando Alberdi	734-418-4264
69267	Brenda Hefti	650-837-7000
69738	Andrew Chipouras	269-337-7756
71343	Li Gao	517-484-8282
72777	Grant Griffith	248-566-8502

Proceeding Documents

Notice: refund approved NOTICE

2025-10-06 FILING PARTY: BOARD

Download

Request for Refund OTHER

2025-10-03 FILING PARTY: PETITIONER

Download

Institution Decision: Deny DECISION

2025-06-04 FILING PARTY: BOARD

Download

Patent Owner's Update to Mandatory Notices NOTICE

2025-05-01 FILING PARTY: PATENT OWNER

Download

Patent Owner's Update to Mandatory Notices NOTICE

2025-04-08 FILING PARTY: PATENT OWNER

Download

Azurity Pharmaceuticals, Inc. vs. EXELIXIS, INC.

Proceeding Overview

Parties & Counsel

Petitioner

Azurity Pharmaceuticals, Inc.

Represented By

Patent Owner / Respondent

EXELIXIS, INC.

Represented By

Tribunal & Venue

Patent Information

Address and Attorney/Agent Information

Power of Attorney & Correspondence

Attorney / Agent Information

Proceeding Documents

Notice: refund approved NOTICE

Request for Refund OTHER

Institution Decision: Deny DECISION

Patent Owner's Update to Mandatory Notices NOTICE

Patent Owner's Update to Mandatory Notices NOTICE

File History (Partial) for U.S.S.N. 16/151,653 Exhibit

File History (Partial) for U.S.S.N. 17/152,394 Exhibit

File History (Partial) for U.S.S.N. 16/706,323 Exhibit

File History (Partial) for U.S.S.N. 13/984,559 Part 2 of 2 Exhibit

Trial Tr. Vol. 1, Oct. 23, 2023 Exhibit

File History (Partial) for U.S.S.N. 13/984,559 Part 1 of 2 Exhibit

PCT Request I.A. No. PCT/US2012/024591 Exhibit

Trial Tr. Vol. 2, Oct. 24, 2023 Exhibit

MSN's Opening Invalidity Brief, Dec. 12, 2023 Exhibit

Trial Tr. Vol. 3, Oct. 25, 2023 Exhibit

File History (Partial) for U.S.S.N. 15/348,716 Exhibit

Intl. Publication No. WO2012/109510 A1 Exhibit

File History (Partial) for U.S.S.N. 17/170,275 Exhibit

Trial Tr. Vol 4, Oct. 26, 2023 Exhibit

Patent Owner's Preliminary Response POPR

File History (Partial) for U.S.S.N. 18/436,836 Exhibit

Patent Owner's Update to Mandatory Notices NOTICE

Supplemental Mandatory Notice Re: Related Matters NOTICE

Notice: Notice filing date accorded NOTICE

Notice : Mandatory Notice NOTICE

Notice : Power of Attorney NOTICE

U.S. Patent 9,717,720 ("Wilson") Exhibit

U.S. Application Serial No. 16/151,653 (Prosecution History Excerpt) Exhibit

U.S. Application Serial No. 17/170,275 (Prosecution History Excerpt) Exhibit

D.I. 162 Exelixis v. MSN, 22-cv-00228-RGA Exhibit

FDA - Guidance for Industry, Genotoxic and Carcinogenic Impurities (2008) Exhibit

Remington - The Science and Practice of Pharmacy (2005) Exhibit

WO 2010/083414 ("Brown") Exhibit

Gibson - Pharmaceutical Preformulation and Formulation (2009) Exhibit

Rowe et al. "Handbook of Pharmaceutical Excipients" Exhibit

Declaration of Graham Buckton, Ph.D. Exhibit

Declaration of William Dichtel, Ph.D. Exhibit

Furuta et al. Exhibit

Notice : Power of Attorney NOTICE

U.S. EPA - Toxicological Review of Quinoline (2001) Exhibit

U.S. Provisional Application Serial No. 61/441,520 ("the '520 provisional") Exhibit

Burns et al. "Redox Economy in Organic Synthesis" Exhibit

U.S. Application Serial No. 13/984,559 (Prosecution History Excerpt) Exhibit

COMETRIQ Product Insert Exhibit

U.S. Application Serial No. 17/152,394 (Prosecution History Excerpt) Exhibit

U.S. Patent 11,298,349 ("the '349 patent") Exhibit

Felpin et al. Exhibit

D.I. 176 Exelixis v. MSN, 22-cv-00228-RGA Exhibit

Petition : as filed PETITION

U.S. Patent 7,169,789 ("Kubo") Exhibit

D.I. 175 Exelixis v. MSN, 22-cv-00228-RGA Exhibit

Newhouse et al. "The economies of synthesis" Exhibit

D.I. 186 Exelixis v. MSN, 22-cv-00228-RGA Exhibit

Aulton "Dosage Form Design and Manufacture" Exhibit

EMEA - Guideline on the Limits of Genotoxic Impurities (2006) Exhibit

Hoffmann "Elements of Synthesis Planning" Exhibit

U.S. Patent 7,579,473 ("the '473 patent") Exhibit

CABOMETYX Product Insert Exhibit

U.S. Application Serial No. 15/348,716 (Prosecution History Excerpt) Exhibit

D.I. 163 Exelixis v. MSN, 22-cv-00228-RGA Exhibit

U.S. Application Serial No. 16/706,323 (Prosecution History Excerpt) Exhibit

Pross et al. Exhibit

D.I. 168 Exelixis v. MSN, 22-cv-00228-RGA Exhibit

U.S. Provisional Application Serial No. 61/441,527 ("the '527 provisional") Exhibit